Insight Brief
Trends Influencing Life Sciences Investments: The New Commercial Model
Mar 28, 2025

Over the past decade, the life sciences industry has experienced fundamental shifts leading to declining launch returns, intense margin pressures, and highly complex patient journeys. Looking ahead to the next few years, we anticipate changes of even greater scope and velocity. Dynamics will shift due to several forces — including the impact of the Inflation Reduction Act (IRA) on the product lifecycle, as well as the rise of GLP-1 treatments, technological advances, disruption to traditional care delivery models, and other market pressures that will forge new approaches and ecosystems.

Read the full insight brief to learn more.

Contact Us